With Cipla's shares showing a gain of 0.55% to reach Rs 1,481.30, the stock reflects ongoing market activity in the ...

Stay informed with the Cipla Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of a ...

March quarter earnings brought relief to the Indian stock market as corporate performance exceeded estimates. Nifty 50 ...

According to Moneycontrol analysis, the market sentiment for Cipla is Very Bearish as of June 3, 2025. Cipla is included in ...

Mumbai: Cipla has announced the appointment of Prabhakaran Balakrishnan Nair, presently working as Chief of Quality - Indore ...

The USFDA has classified the inspection as an Official Action Indicated (OAI) and issued Form 483 with one observation post ...

Benchmark equity indices, Sensex and Nifty 50, wrapped up last week on a cautious note, marking a second straight week of ...

For any FDA-approved facility, it is mandatory to conform to the US regulator's cGMP or current Good Manufacturing Practice ...

Cipla, India's third-biggest drugmaker by sales, reported a fourth-quarter profit that beat estimates on Tuesday, helped by ...

Cipla, India's No. 3 drugmaker by sales, reported a fourth-quarter profit that beat estimates on Tuesday, helped by strong ...

Cipla USA Inc. (Cipla USA) announced its continued collaboration with the American Lung Association for the 11th annual LUNG ...

Limited, UK, a wholly owned subsidiary of the Company, has incorporated a new wholly owned subsidiary named 'CiplaRna GmbH' ...